Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer

HAIZHEN YU, YANG WU, JIANYUAN HUANG and SHIZHEN LI
Anticancer Research December 2023, 43 (12) 5475-5484; DOI: https://doi.org/10.21873/anticanres.16750
HAIZHEN YU
1Department of Laboratory, Zhucheng People’s Hospital, Zhucheng, P.R. China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YANG WU
2Department of General Surgery (Thyroid Gland/Blood Vessel), The First People’s Hospital of Neijiang, Neijiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JIANYUAN HUANG
2Department of General Surgery (Thyroid Gland/Blood Vessel), The First People’s Hospital of Neijiang, Neijiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: huangjianyuan7388@163.com
SHIZHEN LI
1Department of Laboratory, Zhucheng People’s Hospital, Zhucheng, P.R. China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zclishizhen@163.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 12 5475-5484
DOI 
https://doi.org/10.21873/anticanres.16750
PubMed 
38030196

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 6, 2023
  • Revision received October 20, 2023
  • Accepted October 24, 2023
  • Published online November 29, 2023.

Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. HAIZHEN YU1,
  2. YANG WU2,
  3. JIANYUAN HUANG2⇑ and
  4. SHIZHEN LI1⇑
  1. 1Department of Laboratory, Zhucheng People’s Hospital, Zhucheng, P.R. China;
  2. 2Department of General Surgery (Thyroid Gland/Blood Vessel), The First People’s Hospital of Neijiang, Neijiang, P.R. China
  1. Correspondence to: Shizhen Li, Department of Laboratory, Zhucheng People’s Hospital, No. 59, Nanhuan Road, Zhucheng 262299, P.R. China. Tel: +86 05366212678, email: zclishizhen{at}163.com;
  2. Correspondence to: Jianyuan Huang, Department of General Surgery (Thyroid Gland/Blood Vessel), The First People’s Hospital of Neijiang, No. 1866, West Section of Han’an Avenue, Neijiang, 641099, P.R. China. Tel: +86 08322082932, e-mail: huangjianyuan7388{at}163.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review
    I. Saranya, V. Sowfika Dharshini, R.L. Akshaya, P. Sakthi Subhashini, N. Selvamurugan
    International Journal of Biological Macromolecules 2024 266
  • Ten Hypermethylated lncRNA Genes Are Specifically Involved in the Initiation, Progression, and Lymphatic and Peritoneal Metastasis of Epithelial Ovarian Cancer
    Eleonora A. Braga, Alexey M. Burdennyy, Leonid A. Uroshlev, Danila M. Zaichenko, Elena A. Filippova, Svetlana S. Lukina, Irina V. Pronina, Iana R. Astafeva, Marina V. Fridman, Tatiana P. Kazubskaya, Vitaly I. Loginov, Alexey A. Dmitriev, Aleksey A. Moskovtsev, Nikolay E. Kushlinskii
    International Journal of Molecular Sciences 2024 25 21
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (12)
Anticancer Research
Vol. 43, Issue 12
December 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
16 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer
HAIZHEN YU, YANG WU, JIANYUAN HUANG, SHIZHEN LI
Anticancer Research Dec 2023, 43 (12) 5475-5484; DOI: 10.21873/anticanres.16750

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer
HAIZHEN YU, YANG WU, JIANYUAN HUANG, SHIZHEN LI
Anticancer Research Dec 2023, 43 (12) 5475-5484; DOI: 10.21873/anticanres.16750
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Clinical Diagnostic Value of circ-ARHGER28 for Breast Cancer and its Effect on MCF 7 Cell Proliferation and Apoptosis
  • Google Scholar

More in this TOC Section

  • C-myc Oncogene Numerical Imbalances Analysis in Laryngeal Squamous Cell Carcinoma
  • Association of Interleukin-12A Genotypes With Nasopharyngeal Carcinoma Risk
  • Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis
Show more Experimental Studies

Similar Articles

Keywords

  • triple-negative breast cancer
  • lncRNA SEMA3B-AS1
  • prognosis
  • disease development
  • cellular processes
  • miR-513c-5p
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire